⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29368329 | 1.00 | — | — | |
| SCHEMBL29367447 | 1.00 | — | — | |
| SCHEMBL29365233 | 1.00 | — | — | |
| SCHEMBL29368002 | 0.98 | — | — | |
| SCHEMBL29367997 | 0.94 | — | — | |
| SCHEMBL29368271 | 0.87 | — | — | |
| SCHEMBL29368043 | 0.80 | — | — | |
| SCHEMBL18917451 | 0.80 | GBA1 (0.31) | — | |
| SCHEMBL29367810 | 0.75 | GBA1 (0.31) | — | |
| SCHEMBL29368368 | 0.75 | GBA1 (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12163087-B2 | Surface treatment agent and method for manufacturing surface treatment body | CENTRAL GLASS COMPANY, LIMITED (JP) | 2024-12-10 | — | — | US | disclosed |
| US-11670498-B2 | Surface treatment agent and surface-treated body manufacturing method | CENTRAL GLASS COMPANY, LIMITED (JP) | 2023-06-06 | — | — | US | disclosed |
| US-20220325156-A1 | Surface Treatment Agent and Method for Manufacturing Surface Treatment Body | CENTRAL GLASS COMPANY, LIMITED (JP) | 2022-10-13 | — | — | US | disclosed |
| EP-3979004-A1 | SURFACE TREATMENT AGENT AND METHOD FOR MANUFACTURING SURFACE TREATMENT BODY | Central Glass Company, Limited (JP) | 2022-04-06 | — | — | EP | disclosed |
| CN-114008538-A | Surface treatment agent and method for producing surface-treated body | 中央硝子株式会社 | 2022-02-01 | — | — | CN | disclosed |